Adoption of a resolution by the Management Board on the issue of shares as part of an authorised share capital increase.

Current report no. 42/2023

Drafting date: 21 September 2023.

Subject: Adoption of a resolution by the Company's Board of Directors on the issue of shares as part of an authorised share capital increase.

Legal basis: Article 56(1)(2) of the Act on Offering - current information.

The Management Board of Captor Therapeutics S.A. with its registered office in Wrocław (the "Company") announces that on 21 September 2023. The Company's Board of Directors adopted a resolution on the issue of not less than 1 (one) but not more than 400,000 (four hundred thousand) series P ordinary bearer shares, within the limits of the Company's authorised capital, excluding, in full, the pre-emptive rights of the Company's existing shareholders.

The share issue is related to the commencement of the book-building process for the offering of new series P bearer shares and the conclusion of the share offering placement agreement, as announced by the Company in current report No. 41/2023 of 21 September 2023.

The Company provides the text of the adopted resolution as an attachment.